Relief Therapeutics Holding SA (RLFTF)
1.39
-0.01
(-0.71%)
USD |
OTCM |
May 03, 16:00
Relief Therapeutics Price to Book Value: 0.2731 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.2731 |
| May 02, 2024 | 0.2751 |
| May 01, 2024 | 0.2751 |
| April 30, 2024 | 0.2751 |
| April 29, 2024 | 0.283 |
| April 26, 2024 | 0.2849 |
| April 25, 2024 | 0.2849 |
| April 24, 2024 | 0.2849 |
| April 23, 2024 | 0.2849 |
| April 22, 2024 | 0.2849 |
| April 19, 2024 | 0.2849 |
| April 18, 2024 | 0.281 |
| April 17, 2024 | 0.2751 |
| April 16, 2024 | 0.2653 |
| April 15, 2024 | 0.2594 |
| April 12, 2024 | 0.2849 |
| April 11, 2024 | 0.2849 |
| April 10, 2024 | 0.2947 |
| April 09, 2024 | 0.2849 |
| April 08, 2024 | 0.2855 |
| April 05, 2024 | 0.2947 |
| April 04, 2024 | 0.281 |
| April 03, 2024 | 0.2702 |
| April 02, 2024 | 0.2849 |
| April 01, 2024 | 0.283 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.2849 |
| March 27, 2024 | 0.3046 |
| March 26, 2024 | 0.3065 |
| March 25, 2024 | 0.3223 |
| March 22, 2024 | 0.314 |
| March 21, 2024 | 0.2879 |
| March 20, 2024 | 0.3164 |
| March 19, 2024 | 0.3144 |
| March 18, 2024 | 0.3144 |
| March 15, 2024 | 0.3065 |
| March 14, 2024 | 0.3144 |
| March 13, 2024 | 0.3223 |
| March 12, 2024 | 0.3223 |
| March 11, 2024 | 0.3301 |
| March 08, 2024 | 0.3282 |
| March 07, 2024 | 0.3419 |
| March 06, 2024 | 0.336 |
| March 05, 2024 | 0.3085 |
| March 04, 2024 | 0.336 |
| March 01, 2024 | 0.3478 |
| February 29, 2024 | 0.3439 |
| February 28, 2024 | 0.3537 |
| February 27, 2024 | 0.3635 |
| February 26, 2024 | 0.3635 |
| February 23, 2024 | 0.3753 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2201
Minimum
Dec 20 2023
70.58
Maximum
Aug 06 2020
8.101
Average
1.24
Median
Price to Book Value Benchmarks
| AC Immune SA | 1.236 |
| CRISPR Therapeutics AG | 2.520 |
| Addex Therapeutics Ltd | 7.014 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.6225 |
Price to Book Value Related Metrics
| PS Ratio | 2.417 |
| PEG Ratio | -0.0013 |
| Price | 1.39 |
| Earnings Yield | -672.4% |
| Market Cap | 16.98M |
| PEGY Ratio | -0.0013 |